TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy.

Jonathan E Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.